CDC en Español

Search:

ISSN: 1080-6059

  • Email this page

Volume 14, Number 2–February 2008

Research

Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004

Theresa Louise Lamagni,* Shona Neal,* Catherine Keshishian,* Neelam Alhaddad,* Robert George,* Georgia Duckworth,* Jaana Vuopio-Varkila,† and Androulla Efstratiou*
*Health Protection Agency, London, United Kingdom; and †National Public Health Institute, Helsinki, Finland

The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity for 1 contact hour is provided by the Centers for Disease Control and Prevention, which is accredited as a provider of continuing education in nursing by the American Nurses Credentialing Center's Commission on Accreditations.

The Centers for Disease Control and Prevention is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is a designated event for the CHES to receive 1 Category I contact hour in health education, CDC provider number GA0082

CDC has been reviewed and approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 8405 Greensboro Drive, Suite 800, McLean, VA 22102, USA. CDC has awarded 0.1 of CEUs to participants who successfully complete this program.

CDC, our planners, and our presenters wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. George, and he wishes to disclose that he has received honorarium as a speaker for GlaxoSmithKline.

Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use.

Origination Date: January 14, 2008

Expiration Date: January 14, 2011

Directions for obtaining CE credit:

Course Evaluation

Continuing education credit for this activity is available through the CDC Training and Continuing Education Online system only. Please follow the instructions provided below.

To complete online evaluation:

  • Go to CDC/ATSDR Training and Continuing Education Online at http://www.cdc.gov/tceonline. If you have not registered as a participant, click on New Participant to create a user ID and password; otherwise click on Participant Login and login.
  • Once logged on to the CDC/ATSDR Training and Continuing Education Online website, you will be on the Participant Services page. Click on Search and Register. Use either search method to locate the course and click on View.
  • Click on the course. The course information page will come up. Scroll down to Register Here. Click on the type of CE credit that you would like to receive and then Submit. Three demographic questions will come up. Complete the questions and then Submit.
  • If you have already completed the course you may choose to go right to the evaluation. Complete the evaluation and Submit. A record of your course completion and your CE certificate will be located in the Transcript and Certificate section of your record.

If you have any questions or problems contact:
CDC/ATSDR Training and Continuing Education Online
1-800-41TRAIN or 404-639-1292
Email at ce@cdc.gov

After this activity the reader will be able to:

  • Describe the geographic distribution of cases of Streptococcus pyogenes infection.
  • Describe demographic profile of patients with S. pyogenes infection.
  • Describe seasonal patterns of S. pyogenes infection.
  • Describe the clinical presentation of patients with S. pyogenes infection.
  • List 4 risk factors for S. pyogenes infection.
  • List 4 potential public health actions for minimizing the effects of S. pyogenes infection.

Click here to continue to article

Comments to the EID Editors

Please contact the EID Editors at eideditor@cdc.gov

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.

This page posted January 30, 2008
This page last reviewed January 30, 2008

Safer Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435